Evaluation of the CapScan Device to Measure the Metabolism of Sulfasalazine

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

October 15, 2022

Study Completion Date

October 30, 2022

Conditions
Healthy
Interventions
DEVICE

CapScan intestinal sampling device

CapScan is an intestinal collection device used to characterize the regional distribution of sulfasalazine, the metabolic breakdown products of sulfasalazine, and the gut microbiota in the digestive tracts of healthy volunteers.

Trial Locations (1)

94040

Silicon Valley Gastroenterology, Mountain View

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Envivo Bio Inc

INDUSTRY